FYI: FDA habla español

The FDA's watchdogs are putting their language skills to use. Regulatory Focus reports that the regulator issued a Warning Letter to website owner Ramon Rosa for misbranding his products.

Rosa claimed his drugs could treat illnesses including cancer, ringworm, diabetes and arthritis, and the FDA says it has not approved these claims. What makes this Warning Letter different is that it is about materials written in Spanish.

RF notes that the majority of the FDA's promotional monitoring focuses on English language promos, but that it has the authority to review Spanish-language materials if they are published in Puerto Rico—which is where Rosa is based.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.